No Picture
News

Genentech’s TV push for diversity, a rare pioneer’s award, waiting on a big merger — and other Day 2 news from BIO2019

We’re at the Biotechnology Innovation Organization’s 2019 convention ? shorthanded as BIO2019 ? in Philadelphia. Here’s a digest of what we’re seeing and hearing around town. You can follow us on the San Francisco Business Times website, on Twitter @rl… […]

No Picture
News

BioMarin to Participate in Goldman Sachs 40th Annual Global Healthcare Conference on Tuesday, June 11 in Rancho Palos Verdes, CA

SAN RAFAEL, Calif., June 5, 2019 /PRNewswire/ — BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Henry Fuchs, M.D., President, Worldwide Research & Development, will present at the Goldman Sachs 40th Annual Global Healthcare Co… […]

No Picture
News

Amyris Appoints Kathleen Valiasek Chief Business Officer-Appoints Jonathan Wolter as Interim CFO

FLG Partners Veteran Finance Professional to Ensure Smooth Transition and Execution of SEC Filings Compliance Process

EMERYVILLE, Calif., June 4, 2019 /PRNewswire/ –?Amyris, Inc. (Nasdaq:AMRS), a leader in the development and production of sustainab… […]

No Picture
News

Synthego Introduces the Next Generation of CRISPR Knockout Technology with the Gene Knockout Kit v2

Novel bioinformatics-powered multi-guide design guarantees gene knockouts in any human-derived cell type, eliminating trial-and-error in CRISPR guide design

REDWOOD CITY, Calif., June 4, 2019 /PRNewswire/ –?Synthego, a leading genome engineering sol… […]

No Picture
News

BioMarin Announces Approval of Vimizim? (elosulfase alfa) in China for Treatment of Morquio A Syndrome

First and Only Treatment in China Approved for Patients with This Ultra-Rare Genetic ConditionMore than 1,300 Patients Treated with Vimizim in Over 50 Countries

SAN RAFAEL, Calif., June 4, 2019 /PRNewswire/ –?BioMarin Pharmaceutical Inc. (NASDAQ: BM… […]

No Picture
News

Matthew J. Meyer Joins Wilson Sonsini Goodrich & Rosati’s Life Sciences Practice as Chief Client Corporate Development Advisor

— Meyer to lead development of firm’s life science business advisory practice–brings extensive start-up and established biopharma, med tech and diagnostic commercial, business development and strategic experience to role —

PALO ALTO, Calif., June … […]

No Picture
News

Data Presented at ASCO Shows Natera’s Signatera Test Detects Immunotherapy Treatment Response in Metastatic Cancers

Results Support Use of New Blood Test as Surrogate Endpoint in Clinical Trials Assessing Immune Checkpoint Inhibitor Effectiveness

SAN CARLOS, Calif., June 3, 2019 /PRNewswire/ — A new study demonstrates the ability of Natera’s Signatera? test to as… […]